HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Semiquantitative characterization of hepatocellular carcinoma (HCC)--perfusion with contrast-enhanced ultrasound and perfusion analysis.

AbstractBACKGROUND:
At the moment, there is only poor specificity of HCC-detection in tumors smaller than 2 cm in a cirrhotic liver. Thus, efforts have to be made to optimize the distinction between regenerative nodules and HCC.
AIMS:
The aim of our study was to describe the particular perfusion pattern of hepatocellular carcinoma using a specific quantification software.
METHODS:
We evaluated 25 patients with proven hepatocellular carcinoma, who underwent dynamic contrast-enhanced ultrasound (CEUS) using a second generation contrast agent (SonoVue, Bracco, Germany). Retrospectively, we applied the quantification software Qontrast (Bracco, Milan, Italy) to obtain contrast-enhanced sonographic perfusion maps for each lesion.
RESULTS:
We found a close positive correlation of the perfusion parameters peak, time-to-peak and regional blood volume between the entire tumors, the center (center/total) and the periphery of the tumors (periphery/total), respectively. Moreover, we found significant higher peak values, a significant higher regional blood volume and a trend to lower time-to-peak in the center of the tumors compared to the tumor periphery.
CONCLUSION:
These results suggest a better established vascular bed in the center of the tumors. This could be a sonographic marker of HCC in contrast to regenerative nodules.
AuthorsD Schacherer, C Girlich, R Wiest, R Büttner, J Schölmerich, S Feuerbach, N Zorger, O W Hamer, E M Jung
JournalClinical hemorheology and microcirculation (Clin Hemorheol Microcirc) Vol. 44 Issue 2 Pg. 97-105 ( 2010) ISSN: 1875-8622 [Electronic] Netherlands
PMID20203364 (Publication Type: Journal Article)
Chemical References
  • Contrast Media
  • Phospholipids
  • alpha-Fetoproteins
  • contrast agent BR1
  • Sulfur Hexafluoride
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Hepatocellular (blood supply, diagnostic imaging, metabolism, pathology)
  • Contrast Media (administration & dosage)
  • Female
  • Humans
  • Liver Cirrhosis (etiology, pathology)
  • Liver Neoplasms (blood supply, diagnostic imaging, metabolism, pathology)
  • Male
  • Middle Aged
  • Perfusion (methods)
  • Phospholipids (administration & dosage)
  • Sulfur Hexafluoride (administration & dosage)
  • Ultrasonography
  • alpha-Fetoproteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: